{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:37:29Z","timestamp":1771857449468,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"crossref","award":["R01AI120989"],"award-info":[{"award-number":["R01AI120989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10875-019-00711-7","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T03:02:37Z","timestamp":1574391757000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["How I Manage Natural Killer Cell Deficiency"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-7725","authenticated-orcid":false,"given":"Jordan S.","family":"Orange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"issue":"1","key":"711_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/eji.201747294","volume":"49","author":"AI Lim","year":"2019","unstructured":"Lim AI, Di Santo JP. ILC-poiesis: ensuring tissue ILC differentiation at the right place and time. Eur J Immunol. 2019;49(1):11\u20138. https:\/\/doi.org\/10.1002\/eji.201747294.","journal-title":"Eur J Immunol"},{"issue":"8","key":"711_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41590-018-0164-5","volume":"19","author":"JS Orange","year":"2018","unstructured":"Orange JS, Mace EM, French AR, Yokoyama WM, Fehniger TA, Cooper MA. Comment on: evidence of innate lymphoid cell redundancy in humans. Nat Immunol. 2018;19(8):788\u20139. https:\/\/doi.org\/10.1038\/s41590-018-0164-5.","journal-title":"Nat Immunol"},{"issue":"5","key":"711_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503\u201310. https:\/\/doi.org\/10.1038\/ni1582.","journal-title":"Nat Immunol"},{"key":"711_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.coviro.2019.02.005","volume":"34","author":"A Ali","year":"2019","unstructured":"Ali A, Gyurova IE, Waggoner SN. Mutually assured destruction: the cold war between viruses and natural killer cells. Curr Opin Virol. 2019;34:130\u20139. https:\/\/doi.org\/10.1016\/j.coviro.2019.02.005.","journal-title":"Curr Opin Virol"},{"key":"711_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.smim.2017.08.002","volume":"31","author":"KJ Malmberg","year":"2017","unstructured":"Malmberg KJ, Carlsten M, Bjorklund A, Sohlberg E, Bryceson YT, Ljunggren HG. Natural killer cell-mediated immunosurveillance of human cancer. Semin Immunol. 2017;31:20\u20139. https:\/\/doi.org\/10.1016\/j.smim.2017.08.002.","journal-title":"Semin Immunol"},{"issue":"20","key":"711_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/bdr2.1419","volume":"110","author":"DK Sojka","year":"2018","unstructured":"Sojka DK, Yang L, Yokoyama WM. Uterine natural killer cells: to protect and to nurture. Birth Defects Res. 2018;110(20):1531\u20138. https:\/\/doi.org\/10.1002\/bdr2.1419.","journal-title":"Birth Defects Res"},{"issue":"3","key":"711_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12026-015-8664-y","volume":"62","author":"LS Angelo","year":"2015","unstructured":"Angelo LS, Banerjee PP, Monaco-Shawver L, Rosen JB, Makedonas G, Forbes LR, et al. Practical NK cell phenotyping and variability in healthy adults. Immunol Res. 2015;62(3):341\u201356. https:\/\/doi.org\/10.1007\/s12026-015-8664-y.","journal-title":"Immunol Res"},{"issue":"5","key":"711_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","volume":"47","author":"AG Freud","year":"2017","unstructured":"Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA. The broad spectrum of human natural killer cell diversity. Immunity. 2017;47(5):820\u201333. https:\/\/doi.org\/10.1016\/j.immuni.2017.10.008.","journal-title":"Immunity."},{"key":"711_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.smim.2017.08.012","volume":"31","author":"CD Geary","year":"2017","unstructured":"Geary CD, Sun JC. Memory responses of natural killer cells. Semin Immunol. 2017;31:11\u20139. https:\/\/doi.org\/10.1016\/j.smim.2017.08.012.","journal-title":"Semin Immunol"},{"issue":"5","key":"711_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","volume":"16","author":"S Sivori","year":"2019","unstructured":"Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC, Moretta L. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol. 2019;16(5):430\u201341. https:\/\/doi.org\/10.1038\/s41423-019-0206-4.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"711_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.cll.2018.08.001","volume":"38","author":"R Rajalingam","year":"2018","unstructured":"Rajalingam R. Diversity of killer cell immunoglobulin-like receptors and disease. Clin Lab Med. 2018;38(4):637\u201353. https:\/\/doi.org\/10.1016\/j.cll.2018.08.001.","journal-title":"Clin Lab Med"},{"key":"711_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3389\/fimmu.2019.01415","volume":"10","author":"M Vitale","year":"2019","unstructured":"Vitale M, Cantoni C, Della Chiesa M, Ferlazzo G, Carlomagno S, Pende D, et al. An historical overview: the discovery of how NK cells can kill enemies, recruit defense troops, and more. Front Immunol. 2019;10:1415. https:\/\/doi.org\/10.3389\/fimmu.2019.01415.","journal-title":"Front Immunol"},{"issue":"11","key":"711_CR13","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ni1102-1006","volume":"3","author":"JS Orange","year":"2002","unstructured":"Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL. Viral evasion of natural killer cells. Nat Immunol. 2002;3(11):1006\u201312. https:\/\/doi.org\/10.1038\/ni1102-1006.","journal-title":"Nat Immunol"},{"issue":"1","key":"711_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.coi.2007.11.002","volume":"20","author":"S Jonjic","year":"2008","unstructured":"Jonjic S, Babic M, Polic B, Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol. 2008;20(1):30\u20138. https:\/\/doi.org\/10.1016\/j.coi.2007.11.002.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"711_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007658","volume":"15","author":"P Martinez-Vicente","year":"2019","unstructured":"Martinez-Vicente P, Farre D, Sanchez C, Alcami A, Engel P, Angulo A. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor. PLoS Pathog. 2019;15(4):e1007658. https:\/\/doi.org\/10.1371\/journal.ppat.1007658.","journal-title":"PLoS Pathog"},{"issue":"3","key":"711_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/icb.2013.96","volume":"92","author":"EM Mace","year":"2014","unstructured":"Mace EM, Dongre P, Hsu HT, Sinha P, James AM, Mann SS, et al. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol Cell Biol. 2014;92(3):245\u201355. https:\/\/doi.org\/10.1038\/icb.2013.96.","journal-title":"Immunol Cell Biol"},{"issue":"9","key":"711_CR17","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.4049\/jimmunol.1701500","volume":"200","author":"LA Gwalani","year":"2018","unstructured":"Gwalani LA, Orange JS. Single degranulations in NK cells can mediate target cell killing. J Immunol. 2018;200(9):3231\u201343. https:\/\/doi.org\/10.4049\/jimmunol.1701500.","journal-title":"J Immunol"},{"issue":"9","key":"711_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nri2381","volume":"8","author":"JS Orange","year":"2008","unstructured":"Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol. 2008;8(9):713\u201325. https:\/\/doi.org\/10.1038\/nri2381.","journal-title":"Nat Rev Immunol"},{"key":"711_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coi.2017.08.004","volume":"49","author":"FE Sepulveda","year":"2017","unstructured":"Sepulveda FE, de Saint Basile G. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol. 2017;49:20\u20136. https:\/\/doi.org\/10.1016\/j.coi.2017.08.004.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"711_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","volume":"132","author":"IK Chinn","year":"2018","unstructured":"Chinn IK, Eckstein OS, Peckham-Gregory EC, Goldberg BR, Forbes LR, Nicholas SK, et al. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. 2018;132(1):89\u2013100. https:\/\/doi.org\/10.1182\/blood-2017-11-814244.","journal-title":"Blood"},{"issue":"3","key":"711_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/icb.2014.1","volume":"92","author":"ND Huntington","year":"2014","unstructured":"Huntington ND. The unconventional expression of IL-15 and its role in NK cell homeostasis. Immunol Cell Biol. 2014;92(3):210\u20133. https:\/\/doi.org\/10.1038\/icb.2014.1.","journal-title":"Immunol Cell Biol"},{"key":"711_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fimmu.2014.00002","volume":"5","author":"H Ham","year":"2014","unstructured":"Ham H, Billadeau DD. Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity. Front Immunol. 2014;5:2. https:\/\/doi.org\/10.3389\/fimmu.2014.00002.","journal-title":"Front Immunol"},{"issue":"1","key":"711_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/imr.12725","volume":"287","author":"EM Mace","year":"2019","unstructured":"Mace EM, Orange JS. Emerging insights into human health and NK cell biology from the study of NK cell deficiencies. Immunol Rev. 2019;287(1):202\u201325. https:\/\/doi.org\/10.1111\/imr.12725.","journal-title":"Immunol Rev"},{"issue":"15","key":"711_CR24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S1286-4579(02)00038-2","volume":"4","author":"JS Orange","year":"2002","unstructured":"Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 2002;4(15):1545\u201358.","journal-title":"Microbes Infect"},{"key":"711_CR25","unstructured":"Orange JS. NK cell deficiency syndromes. In: Rose B, (ed) UpToDate. Waltham 2018. https:\/\/www.uptodate.com\/home\/how-use-uptodate-presentation"},{"issue":"3","key":"711_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","volume":"132","author":"JS Orange","year":"2013","unstructured":"Orange JS. Natural killer cell deficiency. J Allergy Clin Immunol. 2013;132(3):515\u201325. https:\/\/doi.org\/10.1016\/j.jaci.2013.07.020.","journal-title":"J Allergy Clin Immunol"},{"key":"711_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clim.2015.11.004","volume":"177","author":"M Voss","year":"2017","unstructured":"Voss M, Bryceson YT. Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans. Clin Immunol. 2017;177:29\u201342. https:\/\/doi.org\/10.1016\/j.clim.2015.11.004.","journal-title":"Clin Immunol"},{"issue":"6","key":"711_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/ACI.0000000000000317","volume":"16","author":"EM Mace","year":"2016","unstructured":"Mace EM. Requirements for human natural killer cell development informed by primary immunodeficiency. Curr Opin Allergy Clin Immunol. 2016;16(6):541\u20138. https:\/\/doi.org\/10.1097\/ACI.0000000000000317.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"711_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/B978-0-12-405546-9.00039-X","volume-title":"Stiehm\u2019s immune deficiencies","author":"JS Orange","year":"2014","unstructured":"Orange JS. Natural killer cell deficiency. In: Sullivan KE, Stiehm ER, editors. Stiehm\u2019s immune deficiencies. London: Elsevier\/AP; 2014. p. 765\u201372."},{"issue":"14","key":"711_CR30","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","volume":"121","author":"EM Mace","year":"2013","unstructured":"Mace EM, Hsu AP, Monaco-Shawver L, Makedonas G, Rosen JB, Dropulic L, et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood. 2013;121(14):2669\u201377. https:\/\/doi.org\/10.1182\/blood-2012-09-453969.","journal-title":"Blood."},{"issue":"6","key":"711_CR31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","volume":"123","author":"MA Spinner","year":"2014","unstructured":"Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809\u201321. https:\/\/doi.org\/10.1182\/blood-2013-07-515528.","journal-title":"Blood."},{"issue":"5","key":"711_CR32","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1172\/JCI90727","volume":"127","author":"J Cottineau","year":"2017","unstructured":"Cottineau J, Kottemann MC, Lach FP, Kang YH, Vely F, Deenick EK, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127(5):1991\u20132006. https:\/\/doi.org\/10.1172\/JCI90727.","journal-title":"J Clin Invest"},{"issue":"1","key":"711_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1172\/JCI86276","volume":"127","author":"EM Mace","year":"2017","unstructured":"Mace EM, Bigley V, Gunesch JT, Chinn IK, Angelo LS, Care MA, et al. Biallelic mutations in IRF8 impair human NK cell maturation and function. J Clin Invest. 2017;127(1):306\u201320. https:\/\/doi.org\/10.1172\/JCI86276.","journal-title":"J Clin Invest"},{"issue":"3","key":"711_CR34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/JCI61014","volume":"122","author":"L Gineau","year":"2012","unstructured":"Gineau L, Cognet C, Kara N, Lach FP, Dunne J, Veturi U, et al. Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest. 2012;122(3):821\u201332. https:\/\/doi.org\/10.1172\/JCI61014.","journal-title":"J Clin Invest"},{"issue":"3","key":"711_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1172\/JCI60224","volume":"122","author":"CR Hughes","year":"2012","unstructured":"Hughes CR, Guasti L, Meimaridou E, Chuang CH, Schimenti JC, King PJ, et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest. 2012;122(3):814\u201320. https:\/\/doi.org\/10.1172\/JCI60224.","journal-title":"J Clin Invest"},{"issue":"4","key":"711_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jaci.2015.04.021","volume":"136","author":"S Hanna","year":"2015","unstructured":"Hanna S, Beziat V, Jouanguy E, Casanova JL, Etzioni A. A homozygous mutation of RTEL1 in a child presenting with an apparently isolated natural killer cell deficiency. J Allergy Clin Immunol. 2015;136(4):1113\u20134. https:\/\/doi.org\/10.1016\/j.jaci.2015.04.021.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"711_CR37","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1172\/JCI64837","volume":"122","author":"JT Grier","year":"2012","unstructured":"Grier JT, Forbes LR, Monaco-Shawver L, Oshinsky J, Atkinson TP, Moody C, et al. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest. 2012;122(10):3769\u201380. https:\/\/doi.org\/10.1172\/JCI64837.","journal-title":"J Clin Invest"},{"issue":"3","key":"711_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1365-2249.1996.tb08295.x","volume":"103","author":"S Jawahar","year":"1996","unstructured":"Jawahar S, Moody C, Chan M, Finberg R, Geha R, Chatila T. Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clin Exp Immunol. 1996;103(3):408\u201313.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"711_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/ACI.0000000000000011","volume":"13","author":"E Jouanguy","year":"2013","unstructured":"Jouanguy E, Gineau L, Cottineau J, Beziat V, Vivier E, Casanova JL. Inborn errors of the development of human natural killer cells. Curr Opin Allergy Clin Immunol. 2013;13(6):589\u201395. https:\/\/doi.org\/10.1097\/ACI.0000000000000011.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"711_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fimmu.2016.00545","volume":"7","author":"EM Mace","year":"2016","unstructured":"Mace EM, Orange JS. Genetic causes of human NK cell deficiency and their effect on NK cell subsets. Front Immunol. 2016;7:545. https:\/\/doi.org\/10.3389\/fimmu.2016.00545.","journal-title":"Front Immunol"},{"issue":"26","key":"711_CR41","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","volume":"320","author":"CA Biron","year":"1989","unstructured":"Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320(26):1731\u20135.","journal-title":"N Engl J Med"},{"issue":"4","key":"711_CR42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1086\/503269","volume":"78","author":"C Eidenschenk","year":"2006","unstructured":"Eidenschenk C, Dunne J, Jouanguy E, Fourlinnie C, Gineau L, Bacq D, et al. A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet. 2006;78(4):721\u20137.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"711_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jpeds.2004.11.022","volume":"146","author":"A Etzioni","year":"2005","unstructured":"Etzioni A, Eidenschenk C, Katz R, Beck R, Casanova JL, Pollack S. Fatal varicella associated with selective natural killer cell deficiency. J Pediatr. 2005;146(3):423\u20135.","journal-title":"J Pediatr"},{"issue":"1 Pt 1","key":"711_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1542\/peds.113.1.136","volume":"113","author":"F Bernard","year":"2004","unstructured":"Bernard F, Picard C, Cormier-Daire V, Eidenschenk C, Pinto G, Bustamante JC, et al. A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells. Pediatrics. 2004;113(1 Pt 1):136\u201341.","journal-title":"Pediatrics."},{"issue":"12","key":"711_CR45","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.4049\/jimmunol.177.12.8835","volume":"177","author":"C Eidenschenk","year":"2006","unstructured":"Eidenschenk C, Jouanguy E, Alcais A, Mention JJ, Pasquier B, Fleckenstein IM, et al. Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes. J Immunol. 2006;177(12):8835\u201343. https:\/\/doi.org\/10.4049\/jimmunol.177.12.8835.","journal-title":"J Immunol"},{"issue":"5","key":"711_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/s0022-3476(82)80572-6","volume":"100","author":"G Fleisher","year":"1982","unstructured":"Fleisher G, Starr S, Koven N, Kamiya H, Douglas SD, Henle W. A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr. 1982;100(5):727\u201330. https:\/\/doi.org\/10.1016\/s0022-3476(82)80572-6.","journal-title":"J Pediatr"},{"key":"711_CR47","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3389\/fimmu.2019.01703","volume":"10","author":"WY Moon","year":"2019","unstructured":"Moon WY, Powis SJ. Does natural killer cell deficiency (NKD) increase the risk of cancer? NKD may increase the risk of some virus induced cancer. Front Immunol. 2019;10:1703. https:\/\/doi.org\/10.3389\/fimmu.2019.01703.","journal-title":"Front Immunol"},{"issue":"17","key":"711_CR48","doi-asserted-by":"publisher","first-page":"11351","DOI":"10.1073\/pnas.162376099","volume":"99","author":"JS Orange","year":"2002","unstructured":"Orange JS, Ramesh N, Remold-O\u2019Donnell E, Sasahara Y, Koopman L, Byrne M, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A. 2002;99(17):11351\u20136. https:\/\/doi.org\/10.1073\/pnas.162376099.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6 Pt 1","key":"711_CR49","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/s0022-3476(05)82002-5","volume":"125","author":"KE Sullivan","year":"1994","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6 Pt 1):876\u201385. https:\/\/doi.org\/10.1016\/s0022-3476(05)82002-5.","journal-title":"J Pediatr"},{"issue":"10","key":"711_CR50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","volume":"5","author":"EM Reiche","year":"2004","unstructured":"Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5(10):617\u201325. https:\/\/doi.org\/10.1016\/S1470-2045(04)01597-9.","journal-title":"Lancet Oncol"},{"issue":"3","key":"711_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/brbi.2000.0597","volume":"15","author":"EP Zorrilla","year":"2001","unstructured":"Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun. 2001;15(3):199\u2013226. https:\/\/doi.org\/10.1006\/brbi.2000.0597.","journal-title":"Brain Behav Immun"},{"key":"711_CR52","doi-asserted-by":"publisher","unstructured":"Goyos A, Fort M, Sharma A, Lebrec H. Current concepts in natural killer cell biology and application to drug safety assessments. Toxicol Sci. 2019. https:\/\/doi.org\/10.1093\/toxsci\/kfz098.","DOI":"10.1093\/toxsci\/kfz098"},{"issue":"3","key":"711_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0300-483X(02)00613-3","volume":"185","author":"K Cederbrant","year":"2003","unstructured":"Cederbrant K, Marcusson-Stahl M, Condevaux F, Descotes J. NK-cell activity in immunotoxicity drug evaluation. Toxicology. 2003;185(3):241\u201350.","journal-title":"Toxicology."},{"issue":"2","key":"711_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijpam.2018.05.004","volume":"5","author":"A Alsweed","year":"2018","unstructured":"Alsweed A, Alsuhibani M, Casanova JL, Al-Hajjar S. Approach to recurrent herpes simplex encephalitis in children. Int J Pediatr Adolesc Med. 2018;5(2):35\u20138. https:\/\/doi.org\/10.1016\/j.ijpam.2018.05.004.","journal-title":"Int J Pediatr Adolesc Med"},{"issue":"8","key":"711_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181134","volume":"12","author":"S Mahapatra","year":"2017","unstructured":"Mahapatra S, Mace EM, Minard CG, Forbes LR, Vargas-Hernandez A, Duryea TK, et al. High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults. PLoS One. 2017;12(8):e0181134. https:\/\/doi.org\/10.1371\/journal.pone.0181134.","journal-title":"PLoS One"},{"issue":"9","key":"711_CR56","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","volume":"129","author":"T Lamy","year":"2017","unstructured":"Lamy T, Moignet A, Loughran TP Jr. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129(9):1082\u201394. https:\/\/doi.org\/10.1182\/blood-2016-08-692590.","journal-title":"Blood."},{"issue":"22","key":"711_CR57","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood-2016-12-753830","volume":"129","author":"TS Rubin","year":"2017","unstructured":"Rubin TS, Zhang K, Gifford C, Lane A, Choo S, Bleesing JJ, et al. Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH. Blood. 2017;129(22):2993\u20139. https:\/\/doi.org\/10.1182\/blood-2016-12-753830.","journal-title":"Blood."},{"key":"711_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2014.12.020","volume":"45","author":"N Gotlieb","year":"2015","unstructured":"Gotlieb N, Rosenne E, Matzner P, Shaashua L, Sorski L, Ben-Eliyahu S. The misleading nature of in vitro and ex vivo findings in studying the impact of stress hormones on NK cell cytotoxicity. Brain Behav Immun. 2015;45:277\u201386. https:\/\/doi.org\/10.1016\/j.bbi.2014.12.020.","journal-title":"Brain Behav Immun"},{"issue":"17","key":"711_CR59","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2011-10-385377","volume":"119","author":"RK Shaw","year":"2012","unstructured":"Shaw RK, Issekutz AC, Fraser R, Schmit P, Morash B, Monaco-Shawver L, et al. Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency. Blood. 2012;119(17):4009\u201312. https:\/\/doi.org\/10.1182\/blood-2011-10-385377.","journal-title":"Blood."},{"key":"711_CR60","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3389\/fimmu.2017.01869","volume":"8","author":"JI Cohen","year":"2017","unstructured":"Cohen JI. GATA2 Deficiency and Epstein-Barr virus disease. Front Immunol. 2017;8:1869. https:\/\/doi.org\/10.3389\/fimmu.2017.01869.","journal-title":"Front Immunol"},{"issue":"2","key":"711_CR61","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4049\/jimmunol.121.2.532","volume":"121","author":"D Santoli","year":"1978","unstructured":"Santoli D, Trinchieri G, Koprowski H. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol. 1978;121(2):532\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"711_CR62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-5728(97)00146-X","volume":"82","author":"H Bolay","year":"1998","unstructured":"Bolay H, Karabudak R, Aybay C, Candemir H, Varli K, Imir T, et al. Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity. J Neuroimmunol. 1998;82(2):109\u201315.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"711_CR63","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/1097-0142(19891001)64:7<1383::AID-CNCR2820640702>3.0.CO;2-I","volume":"64","author":"A Evans","year":"1989","unstructured":"Evans A, Main E, Zier K, Ikegaki N, Tartaglione M, Kennett R, et al. The effects of gamma interferon on the natural killer and tumor cells of children with neuroblastoma. A preliminary report. Cancer. 1989;64(7):1383\u20137.","journal-title":"Cancer."},{"issue":"4","key":"711_CR64","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1084\/jem.160.4.1147","volume":"160","author":"G Trinchieri","year":"1984","unstructured":"Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med. 1984;160(4):1147\u201369.","journal-title":"J Exp Med"},{"issue":"1","key":"711_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI116161","volume":"91","author":"MA Caligiuri","year":"1993","unstructured":"Caligiuri MA, Murray C, Robertson MJ, Wang E, Cochran K, Cameron C, et al. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest. 1993;91(1):123\u201332. https:\/\/doi.org\/10.1172\/JCI116161.","journal-title":"J Clin Invest"},{"key":"711_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2017.02.001","volume":"179","author":"S Jyonouchi","year":"2017","unstructured":"Jyonouchi S, Gwafila B, Gwalani LA, Ahmad M, Moertel C, Holbert C, et al. Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome. Clin Immunol. 2017;179:47\u201353. https:\/\/doi.org\/10.1016\/j.clim.2017.02.001.","journal-title":"Clin Immunol"},{"issue":"4","key":"711_CR67","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpeds.2005.06.028","volume":"148","author":"LD Notarangelo","year":"2006","unstructured":"Notarangelo LD, Mazzolari E. Natural killer cell deficiencies and severe varicella infection. J Pediatr. 2006;148(4):563\u20134 author reply 4.","journal-title":"J Pediatr"},{"issue":"5","key":"711_CR68","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jaci.2015.12.1311","volume":"137","author":"S Naik","year":"2016","unstructured":"Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, et al. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol. 2016;137(5):1498\u2013505 e1. https:\/\/doi.org\/10.1016\/j.jaci.2015.12.1311.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00711-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-019-00711-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00711-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:36:53Z","timestamp":1744177013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-019-00711-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s10875-019-00711-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares the following potential conflicts of interest: Royalty received for authorship of Up To Date (Wolters Kluwer Publishing) chapters on NK cell deficiency, and fees received in consultation to manufacturers of therapeutic immunoglobulin ADMA biologics (scientific advisory board membership) and Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}